Navigation Links
Lilly Reports First-Quarter 2011 Results
Date:4/18/2011

pite a significant decline in Gemzar sales due to generic competition. This revenue growth allowed us to make necessary investments in research and development to address the challenges of upcoming patent expirations. We are on track to deliver on our 2011 headcount and expense reduction targets, as well as our goal of having at least ten potential new medicines in Phase 3 clinical development by the end of this year."

Key Events Over the Last Three Months

  • The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending approval of exenatide 2 mg powder and solvent for prolonged release suspension for injection (proposed trade name Bydureon) in the European Union for the treatment of type 2 diabetes in combination with certain oral therapies. The CHMP's positive opinion is now referred for final action by the European Commission, which has the authority to approve medicines for the European Union. The Commission usually makes a decision on CHMP recommendations within two to three months.
  • Late last week, the company received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT), under investigation for the treatment of exocrine pancreatic insufficiency (EPI). The complete response letter communicated the need for Lilly to conduct an additional clinical trial prior to a re-submission. The company will be working diligently to address the agency's questions.
  • The company announced that Axiron® (testosterone) topical solution is available in pharmacies throughout the U.S.
  • The company received a complete response letter from the FDA for the NDA for Amyvid™ (florbetapir F 18 injection), a Positron Emission Tomography (PET) imaging agent under investigation for the detection of beta-amyloid plaque in the brain
    '/>"/>

  • SOURCE Eli Lilly and Company
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

    Related medicine technology :

    1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
    2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
    3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
    4. Lilly Receives NCQA Design Certification for Depression Care Management Program
    5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
    6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
    7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
    8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
    9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
    10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
    11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/21/2014)... -- An International Trade Commission (ITC) ruling issued Friday held ... Taiwanese device manufacturer APEX continues to infringe ResMed patents ... is the innovation leader and pioneer in designing and ... "Our research and development teams are constantly ... comfort, performance and efficacy," said David Pendarvis , ...
    (Date:7/21/2014)... July 21, 2014 Apex Medical Corporation (Apex, ... and Pressure Area Care sectors, announces that the United ... advisory opinion, determining that Apex,s newly designed XT series ... 220 mask are free from the patent claims asserted ... declares its plan of introducing an upgraded iCH water ...
    (Date:7/18/2014)... Hanger, Inc. (NYSE: HGR ) announced today that ... quarter ended June 30, 2014, on Tuesday, August 5, 2014 ... results is scheduled to begin at 9:00 a.m., ET, on ... 1-877-662-6095. A replay will be available until Thursday, August 14, ... About Hanger, Inc. – Built on the legacy ...
    Breaking Medicine Technology:ITC Rules Redesigned APEX Humidifier Still Infringes ResMed Patents 2Apex Medical's Respiratory Therapy Product Receives Affirmation from USITC 2
    (Date:7/22/2014)... 22, 2014 A new and technologically ... laxity with results that are surprising even the most ... the skin with radio frequency, ThermiTight has been dubbed ... under the skin to “inject” heat to the tissues ... this single treatment solution for skin laxity produces results ...
    (Date:7/21/2014)... to target and kill cancer cells could boost the ... help avoid amputation, a new study reports. , Scientists ... effectiveness of a genetically engineered version of the virus ... of the virus alongside isolated limb perfusion chemotherapy ... or leg as an alternative to amputation was ...
    (Date:7/21/2014)... (PRWEB) July 22, 2014 Recently, Stwd.co.uk, a ... of cheap wedding dresses. Additionally, the company’s chief executive officer ... at discounted prices, up to 58% off. , “All our ... The special offer is launched to bring huge benefits to ... collection of cheap wedding outfits. By the way, we offer ...
    (Date:7/21/2014)... USA (PRWEB) July 21, 2014 As ... Rappel Down Westin Hotel to Raise Addiction Awareness (7/15), ... by rappelling down a 27-story building in Downtown Philly. ... in the event at the Westin Convention Center Hotel. ... loved one's addiction. One man participated because his son ...
    (Date:7/21/2014)... July 21, 2014 What do romance, ... have in common? You can find them all in ... novel's main character, Miranda, lives on Martha’s Vineyard with ... a wealthy New Yorker, and becomes entangled in a ... Heart challenges readers to think about what choices they ...
    Breaking Medicine News(10 mins):Health News:New Minimally Invasive Procedure, ThermiTight, “Injects” Radio Frequency to Treat Skin Laxity 2Health News:Viral therapy could boost limb-saving cancer treatment 2Health News:Viral therapy could boost limb-saving cancer treatment 3Health News:2014 Cheap Wedding Dresses, Newest Items Offered by Professional Company Stwd.co.uk 2Health News:100 People Climb Down Building to Raise Drug Addiction Awareness in Philadelphia 2Health News:100 People Climb Down Building to Raise Drug Addiction Awareness in Philadelphia 3Health News:Thea Marsh Releases Debut Novel that Celebrates and Reaches out to Women Everywhere 2
    ... LAFAYETTE, Ind. - A nanoparticle growing in popularity as a ... according to a Purdue University study. Tested on fathead ... of toxicity on aquatic life -- nanosilver suspended in solution ... nanosilver was allowed to settle, the solution became several times ...
    ... ... healthy living and health care, there is a greater demand for online resources which provides ... and about health care. New Website, MeTheDoctor.com, gives readers resources they need to take charge ... ...
    ... ... and CEO of Novasys Medical Inc., will receive the Adaptive Business Leaders Organization (ABL)’s ... Innovations in HealthcareSM Awards Event, on April 28, in Newport Beach, California. , ... Santa Ana, CA (PRWEB) ...
    ... ... ... ... ...
    ... , ... ... ... ...
    ... March 2010 - Think back to your last fight with someone ... you behave? Conflict with a loved one often leaves a person ... these scenarios have become soap opera clichs. After an argument, ... a local bar to drown their sorrows in alcohol. These ...
    Cached Medicine News:Health News:Popular nanoparticle causes toxicity in fish, study shows 2Health News:MeTheDoctor.com Helps Consumers Make Informed Decisions About Their Health 2Health News:Novasys Medical's Debra Reisenthel Named ABL's 2010 “Leadership in Innovation” Awardee 2Health News:Novasys Medical's Debra Reisenthel Named ABL's 2010 “Leadership in Innovation” Awardee 3Health News:National Hispanic Council on Aging Joins the Administration in Mission to Combat Medicare Fraud By Empowering Hispanics 2Health News:National Hispanic Council on Aging Joins the Administration in Mission to Combat Medicare Fraud By Empowering Hispanics 3Health News:National Hispanic Council on Aging Joins the Administration in Mission to Combat Medicare Fraud By Empowering Hispanics 4Health News:National Hispanic Council on Aging Joins the Administration in Mission to Combat Medicare Fraud By Empowering Hispanics 5Health News:AMA Honors California County Supervisor With Top Government Service Award 2Health News:AMA Honors California County Supervisor With Top Government Service Award 3Health News:Don't make that face at me! 2
    ... The SJM Tailor Flexible Band ... a convenient and time-saving alternative for ... It complements the SJM Tailor® Annuloplasty ... who usually implant full rings, but ...
    This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,407-0) or contact custom...
    Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
    ... The AlphaPette Pipettor is the #1 ... Offers accuracy, comfort, and reliability. Continuously ... volume readout sub-micrometer. Easy interchangeable ejector ... tiny hands. Adjustable rapid pipet tip ...
    Medicine Products: